This webinar covers the impact of the Covid-19 pandemic on the manufacturing and delivery of pharmaceuticals. The supply chain process can be rather complex in such an industry, if one component is not present then logistical problems are bound to happen along the way. All these components may originate from different countries, while certain processes may be done in a new set of countries.
With the presence of Covid-19, we face a situation where countries have lockdowns, discontinue manufacturing, close borders, and introduce special controls, which leads to an interruption of supply chains. This is where risk management strategies need to be in place to reduce the risk of drug shortages, or to even overcome the problem.